The article presents a case study of a 60-year-old patient who received lenalidomide for multiple myeloma. Multiple myeloma was diagnosed when the patient was 57 years old where he had been treated with lenalidomide. The patient had developed severe chronic kidney failure that requires dialysis that he had been undergoing for three years as a consequence of the hematological malignancy.